Esther Lee Metlife Inc (MET) insider trading activity

Esther Lee is EVP - Gl. Chief Marketing Off. of METLIFE INC. Currently has a direct ownership of 56,956 shares of MET, which is worth approximately $4.47 Million. The most recent transaction as insider was on Jun 14, 2021, when has been sold 178 shares (Common Stock) at a price of $63.31 per share, resulting in proceeds of $11,269. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57K

0% 3M change

0% 12M change

Total Value Held $4.47 Million

Esther Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2021	BUY Grant, award, or other acquisition	$11,269 $63.31 p/Share	178 Added 0.31%	56,956 Common Stock
May 19 2021	SELL Open market or private sale	$505,128 $64.76 p/Share	7,800 Reduced 12.08%	56,779 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	$10,716 $60.54 p/Share	177 Added 0.27%	64,579 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$41,390 $58.96 p/Share	702 Reduced 1.08%	64,402 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$84,108 $59.44 p/Share	1,415 Reduced 2.13%	65,104 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$476,267 $57.43 p/Share	8,293 Reduced 11.09%	66,519 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	23,720 Added 24.07%	74,812 Common Stock
Dec 14 2020	BUY Grant, award, or other acquisition	$10,589 $45.84 p/Share	231 Added 0.53%	43,144 Common Stock
Sep 14 2020	BUY Grant, award, or other acquisition	$10,447 $38.84 p/Share	269 Added 0.62%	42,913 Common Stock
Jun 12 2020	BUY Grant, award, or other acquisition	$10,336 $37.45 p/Share	276 Added 0.64%	42,643 Common Stock
Mar 13 2020	BUY Grant, award, or other acquisition	$5,619 $31.93 p/Share	176 Added 0.41%	42,367 Common Stock
Mar 02 2020	SELL Payment of exercise price or tax liability	$75,752 $44.56 p/Share	1,700 Reduced 3.87%	42,190 Common Stock
Mar 02 2020	BUY Exercise of conversion of derivative security	-	4,444 Added 9.43%	42,704 Common Stock
Feb 25 2020	SELL Payment of exercise price or tax liability	$11,847 $47.58 p/Share	249 Reduced 0.63%	39,446 Common Stock
Feb 25 2020	BUY Grant, award, or other acquisition	-	9,755 Added 19.73%	39,695 Common Stock
Dec 13 2019	BUY Grant, award, or other acquisition	$5,592 $50.38 p/Share	111 Added 0.37%	29,940 Common Stock
Sep 13 2019	BUY Grant, award, or other acquisition	$5,514 $48.37 p/Share	114 Added 0.38%	29,830 Common Stock
Jun 13 2019	BUY Grant, award, or other acquisition	$5,481 $48.51 p/Share	113 Added 0.38%	29,715 Common Stock
Mar 04 2019	SELL Payment of exercise price or tax liability	$23,058 $45.66 p/Share	505 Reduced 2.86%	17,149 Common Stock
Mar 04 2019	BUY Exercise of conversion of derivative security	-	1,319 Added 6.95%	17,654 Common Stock
Mar 01 2019	SELL Payment of exercise price or tax liability	$73,289 $45.55 p/Share	1,609 Reduced 8.97%	16,335 Common Stock
Mar 01 2019	BUY Exercise of conversion of derivative security	-	4,207 Added 19.82%	17,015 Common Stock
Feb 26 2019	BUY Grant, award, or other acquisition	$570,448 $44.65 p/Share	12,776 Added 32.52%	26,513 Common Stock
Mar 02 2018	SELL Payment of exercise price or tax liability	$93,912 $45.5 p/Share	2,064 Reduced 13.06%	13,737 Common Stock
Mar 02 2018	BUY Exercise of conversion of derivative security	-	4,205 Added 22.26%	14,684 Common Stock

Also insider at

CLX

CLOROX CO Consumer Defensive

Director

Esther Lee

EVP - Gl. Chief Marketing Off.

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MET shares.

Notify only if

Value

Insider Trading

Get notified when an Metlife Inc insider buys or sells MET shares.

Notify only if

Operation

Value

Type

News

Receive news related to METLIFE INC

Track Activities on MET

Account